Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningLeukemiaTransplantation ChimeraLiver TransplantationGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHematopoietic Stem CellsHistocompatibility TestingHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesHematopoiesisKidney TransplantationRecurrenceMice, Inbred C57BLCombined Modality TherapyT-LymphocytesRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsLeukemia, Myeloid, AcuteBone Marrow ExaminationTreatment OutcomeImmunosuppressive AgentsHematologic NeoplasmsRemission InductionGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingLeukemia, MyeloidTransplantation ImmunologyBone Marrow NeoplasmsImmunosuppressionLymphocyte DepletionGraft vs Host ReactionLymphoma, Non-HodgkinAcute DiseaseStem Cell TransplantationLeukocyte TransfusionColony-Forming Units AssayLeukocytes, MononuclearHeart TransplantationFlow CytometryLeukocyte CountHLA AntigensChimeraSevere Combined ImmunodeficiencyCells, CulturedSurvival AnalysisMyelodysplastic SyndromesRetrospective StudiesLung TransplantationCyclosporineGranulocyte Colony-Stimulating FactorPeripheral Blood Stem Cell TransplantationHematologic DiseasesLymphocyte TransfusionLymphocytesCell DifferentiationBlood CellsAntineoplastic Combined Chemotherapy ProtocolsActuarial AnalysisBone DensitySpleenNuclear FamilyAntigens, CD34CarmustineFollow-Up StudiesPancytopeniaImmunophenotypingOrgan TransplantationCytomegalovirus InfectionsCytarabineGraft vs Tumor EffectSurvival RateMice, Inbred BALB CGraft vs Leukemia EffectMelphalanMultiple MyelomaLymphomaCell SeparationLymphocyte ActivationBone ResorptionDisease-Free SurvivalEtoposideAntigens, CD